About Us

cyberDERM, inc. was founded in 1997 by Dr. Gary Grove and his wife Mary Jo.  As the name suggests, our focus is on computerized biomedical research instruments that allow changes in skin structure and function to be monitored non-invasively.  We are the American distributor for the full line of biomedical research instruments manufactured by Cortex Technology and work closely with other leading manufacturers such as Diastron, CuDerm, SciBase, IBS, etc.  We have considerable expertise in biophysical measurements of the skin and can also custom design systems for special needs.

Although cyberDERM was formally incorporated in 1997, our group has nearly 30 years experience in working in close concert with numerous cosmetic and pharmaceutical firms and government regulatory agencies to develop methods for assessing the safety and efficacy of a wide variety of skin products.  Indeed, many of the instrumental testing procedures that are currently being employed to evaluate the safety and efficacy of cosmetics and topically applied drugs were first developed while Dr. Grove was with Dr. Albert Kligman at Duhring Labs and IVY Laboratories from the mid 1970’s to the mid 1980’s.   Dr. Grove was also a co-founder of K.G.L.’s Skin Study Center and was their Vice President of R&D for 20 years.

Our group remains committed to developing and refining innovative bioinstrumental and computerized methods for noninvasive analysis of skin structure, its functions, and effects of topical treatments. We have gained an international reputation for developing innovative testing strategies that meet the needs of our clients in a timely and cost-effective manner.

In response to our clients' ever increasing needs, cyberDERM, inc. has enhanced its capabilities by relocating to expanded facilities that are outfitted with state of the art equipment.  Our well trained and highly experienced staff takes pride in providing quality work you can rely on in substantiating claims and product development plans. All contract work for clients is treated in the strictest confidence and with the utmost care to ensure appropriateness of procedure and accuracy of reporting.